Lessons learned from 2 years experience in intravenous thrombolysis for acute ischemic stroke in a single tertiary medical center

Israel Medical Association Journal

Volumn 11, Issue 12, 2009, Pages 714-718

  Gur, Alexander Y ^a   Shopin, Ludmila ^a   Bornstein, Natan M ^a  

^a NONE

Author keywords

Carotid stenosis; Outcome; Stroke; Thrombolysis; Tissue plasminogen activator

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; LEARNING; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; TERTIARY HEALTH CARE; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MIDDLE AGED; PLASMINOGEN ACTIVATORS; STROKE; THROMBOLYTIC THERAPY;

EID: 75449106168     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007; 38: 1655-711.
2. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25(5): 457-507.
3. Alberts MJ. Hyperacute stroke therapy with tissue plasminogen activator. Am J Cardiol 1997; 80: 29-34D.
4. The European Stroke Initiative Executive Committee and European Stroke Initiative Writing Group. European stroke initiative recommendations for stroke management - update 2003. Cerebrovasc Dis 2003; 16: 311-37.
5. National Acute Stroke Israeli Survey Group. National survey of hospitalized patients, March-April 2007; Preliminary findings. 2007: 25.
6. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359: 1317-29.
7. Wahlgren N, Ahmed N, Davalos A, et al., for the SITS-MOST investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007; 369: 275-82.
8. Wahlgren N, Ahmed N, Eriksson N, et al., for the SITS-MOST investigators. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials; Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST). Stroke 2008; 39: 3316-22.
9. Schwammenthal Y, Tsabari R, Bakon M, Orion D, Merzeliak O, Tanne D. Thrombolysis in acute stroke. IMAJ Isr Med Assoc J 2006; 8: 784-7.
10. Christou I, Felberg RA, Demchuk AM, et al. Intravenous tissue plasminogen activator and flow improvement in acute ischemic stroke patients with internal carotid artery occlusion. J Neuroimaging 2002; 12: 119-23.
11. Linfante I, Llinas RH, Selim M, et al. Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator. Stroke 2002; 33: 2066-71.
12. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-7.
13. Hacke W, Kaste M, Fieschi C, et al., for the ECASS Study Group. Intravenous thrombolysis with recombinant tissue plasminogen activator in acute hemispheric stroke. JAMA 1995; 274: 1017-25.
14. Herndon R. Handbook of Neurologic Rating Scales. New York: Demos Vermande, 1997.
15. Larrue V, von Kummer R, del Zoppo G, Bluhmki E. Hemorrhagic transformation in acute ischemic stroke. Stroke 1997; 28: 957-60.
16. Grant EG, Benson CB, Moneta GL, et al. Carotid artery stenosis: gray-scale and Doppler US diagnosis - Society of Radiologists in Ultrasound Consensus Conference. Radiology 2003; 229: 340-6.
17. Schwammenthal Y, Drescher MJ, Merzeliak O, et al. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience. IMAJ Isr Med Assoc J 2004; 6: 95-6.
18. Koennecke H-C, Nohr R, Leistner S, Marx P. Intravenous tPA for ischemic stroke team performance over time, safety, and efficacy in a single-center, 2-year experience. Stroke 2001; 32: 1074-8.
19. Yoneda Y, Yamamoto S, Hara Y, et al. Post-licensed 1-year experience of systemic thrombolysis with tissue plasminogen activator for ischemic stroke in a Japanese neuro-unit. Clin Neurol Neurosurg 2007; 109: 567-70.
20. Molina CA, Montaner J, Arenillas JF, Ribo M, Rubiera M, Alvarez-Sabin J. Differential pattern of tPA-induced proximal MCA recanalization among stroke subtypes. Stroke 2004; 35: 486-90.
21. Rubiera M, Alvarez-Sabin J, Ribo M, et al. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke. Stroke 2005; 36: 1452-6.
22. Blinc A, Planinsic G, Keber D, et al. Dependence of blood clot lysis on the mode of transport of urokinase into the clot: a magnetic resonance imaging study in vitro. Thromb Haemost 1991; 65: 549-52.
23. Blinc A, Francis CW. Transport processes in fibrinolysis and fibrinolytic therapy. Thromb Haemost 1996; 76: 481-91.